ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: Bayer

Bayer acne drug deemed safe treatment for some women

Bayer acne drug deemed safe treatment for some women

May 17, 2013 8:26 am by | 0 Comments

LONDON (Reuters) - Bayer's acne pill Diane 35 and its generic versions are safe to use in certain women when other options have failed, the European Medicines Agency said on ... Read more
Bayer will buy German herbal medicine maker Steigerwald

Bayer will buy German herbal medicine maker Steigerwald

May 16, 2013 7:44 am by | 0 Comments

FRANKFURT (Reuters) - Germany's largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a maker of herbal treatments.Bayer said on Thursday that Steigerwald, based in Darmstadt, ... Read more
Bayer starts Phase III trial on regorafenib for liver cancer

Bayer starts Phase III trial on regorafenib for liver cancer

May 15, 2013 2:53 am by | 0 Comments

FRANKFURT (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug regorafenib in patients with advanced liver cancer.The drug, also known ... Read more
Bayer core earnings growth tempered by high feedstock costs

Bayer core earnings growth tempered by high feedstock costs

April 25, 2013 1:49 am by | 0 Comments

FRANKFURT (Reuters) - Quarterly underlying core earnings at Bayer, Germany's largest drugmaker, edged 0.4 percent higher as strong demand for its farming pesticides was offset by high raw material costs ... Read more
German cost-benefit agency may cut prices for diabetes, bone, pain drugs

German cost-benefit agency may cut prices for diabetes, bone, pain drugs

April 18, 2013 12:12 pm by | 0 Comments

FRANKFURT (Reuters) - Drugs from Novo Nordisk, Amgen, Bayer and other companies could face price cuts in Germany as the country's medical cost-benefit agency widens a review into the value ... Read more
U.S. court finds Bayer contraceptive patent claim invalid

U.S. court finds Bayer contraceptive patent claim invalid

April 16, 2013 3:10 pm by | 0 Comments

WASHINGTON (Reuters) - A U.S. appeals court has ruled against Bayer AG, a world leader in oral contraceptives, reversing a ruling by a lower court and finding that parts of ... Read more
Bayer lays off 40 employees at St. Joseph location

Bayer lays off 40 employees at St. Joseph location

April 4, 2013 3:59 pm by | 0 Comments

Bayer HealthCare has announced layoffs for approximately 40 employees at its St. Joseph facility.Bayer spokeswoman Staci Gouveia said the reductions relate to Bayer's acquisition of Teva Pharmaceutical Industries' St. Joseph ... Read more
India board rules against Bayer in cancer drug patent case

India board rules against Bayer in cancer drug patent case

March 4, 2013 9:39 am by | 0 Comments

An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for ... Read more
FDA approves Bayer drug for rare gastrointestinal tract cancer

FDA approves Bayer drug for rare gastrointestinal tract cancer

February 25, 2013 2:08 pm by | 0 Comments

WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Monday it has approved Bayer AG's drug Stivarga for the treatment of a rare type of gastrointestinal tract cancer.Stivarga ... Read more
Bayer seeks FDA OK for radium-223 for prostate cancer

Bayer seeks FDA OK for radium-223 for prostate cancer

December 14, 2012 8:46 am by | 0 Comments

FRANKFURT (Reuters) - German drugmaker Bayer said on Friday it requested approval from U.S. regulators for an experimental prostate cancer drug that could eventually generate more than 1 billion euros ... Read more
Bayer: 5 key drugs to have combined peak sales of $7 billion

Bayer: 5 key drugs to have combined peak sales of $7 billion

November 14, 2012 4:47 am by | 0 Comments

LEVERKUSEN, Germany (Reuters) - Bayer said its five most promising new drugs have an annual peak sales potential of more than 5.5 billion euros ($7 billion).The sales forecast comprises anti-clotting ... Read more
Bayer’s regorafenib for gastrointestinal tumors gets priority review by FDA

Bayer’s regorafenib for gastrointestinal tumors gets priority review by FDA

October 29, 2012 12:25 pm by | 0 Comments

FRANKFURT (Reuters) - U.S. health regulators granted a priority review for Bayer's cancer drug regorafenib for the treatment of gastrointestinal stromal tumors, potentially speeding up the treatment's route to market.The ... Read more
Shire CEO Angus Russell to leave in 2013; Bayer’s Flemming Ornskov to take over

Shire CEO Angus Russell to leave in 2013; Bayer’s Flemming Ornskov to take over

October 26, 2012 4:47 am by | 0 Comments

On his 13th anniversary with drugmaker Shire P.L.C., chief executive officer Angus Russell said Thursday he will retire next year and be succeeded by Bayer executive Flemming Ornskov.Shire, a leading ... Read more
Bayer won’t sell its diabetes blood glucose meters unit

Bayer won’t sell its diabetes blood glucose meters unit

October 26, 2012 1:54 am by | 1 Comments

FRANKFURT (Reuters) - Bayer AG has called off the sale of its blood glucose meters business for now, Financial Times Deutschland reported, citing industry and financial sources.According to the paper, ... Read more
Bayer lung drug shows promise in pulmonary hypertension

Bayer lung drug shows promise in pulmonary hypertension

October 22, 2012 12:01 am by | 0 Comments

FRANKFURT (Reuters) - Bayer's experimental riociguat pill showed promise against a life-threatening form of high blood pressure in the lungs, a potential challenge to existing treatments from Actelion and Gilead.In ... Read more